| Sign In to gain access to subscriptions and/or personal tools. |
Novel PSEN1 Mutation in a Bulgarian Patient With Very Early-Onset Alzheimers Disease, Spastic Paraparesis, and Extrapyramidal SignsDepartment of Neurology, Medical University, Sofia, Bulgaria, traykov_l{at}yahoo.fr
Department of Neurology, Medical University, Sofia, Bulgaria
Department of Molecular Medicine Center, Medical University, Sofia, Bulgaria, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium, Department of Neurology, Medical University, Sofia, Bulgaria
Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium
Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium
Department of Chemistry and Biochemistry, Medical University, Sofia, Bulgaria, Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium
Laboratory of Neurogenetics, Institute Born-Bunge and University of Antwerp, Antwerpen, Belgium, Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerpen, Belgium We describe the phenotype of a Bulgarian early-onset Alzheimers disease (EOAD) family with 3 affected patients in 3 generations. In the proband, a novel L381V mutation in the presenilin1 (PSEN1) gene was identified. In this patient, the first symptoms were noticed at the age of 32 years and she died at the age of 37 years. The EOAD phenotype caused by the novel L381V mutation in the PSEN1 gene presented clinically, by a very early onset in the proband, rapid progression of dementia, spastic paraparesis, and extrapyramidal signs, as atypical clinical signs in Alzheimers disease patients.
Key Words: early onset Alzheimers disease presenilin 1 spastic paraparesis parkinsonism
American Journal of Alzheimer's Disease and Other Dementias®, Vol. 24, No. 5,
404-407 (2009) |
|||